Evidence map›Paper›PMID 19381130›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2009

Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder.

Shaohua Chang, Joseph A Hypolite, Sunish Mohanan, Stephen A Zderic, Alan J Wein, Samuel Chacko

Open access · bronzeAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Nerve-sparing Mid-urethral Obstruction (NeMO) in Female Small Rodents.Journal of visualized experiments : JoVE · 2017
    Article
  5. Big-conductance CaChannels (Austin, Tex.) · 2016
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shaohua ChangDivision of Urology, Department of Surgery, University of Pennsylvania, Glenolden, PA, USA.
Joseph A Hypolite
Sunish Mohanan
Stephen A Zderic
Alan J Wein
Samuel Chacko
University of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

Remodeling of Smooth Muscle in Bladder Outlet ObstructionP50DK052620 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI CHACKO, SAMUEL K. · 1998 to 2012
$12.9M
Disruption of Caldesmon Gene Expression in Bladder MyocytesR01DK069898 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI CHACKO, SAMUEL K. · 2005 to 2009
$1.8M
NIDDK NIH HHS P50 DK052620NIDDK NIH HHS P50 DK52620NIDDK NIH HHS R01 DK069898
6 · The paper itself

Abstract

Normal urinary bladder function requires contraction and relaxation of the detrusor smooth muscle (DSM). The DSM undergoes compensatory hypertrophy in response to partial bladder outlet obstruction (PBOO) in both men and animal models. Following bladder hypertrophy, the bladder either retains its normal function (compensated) or becomes dysfunctional (decompensated) with increased voiding frequency and decreased void volume. We analyzed the contractile characteristics of DSM in a rabbit model of PBOO. The protein kinase C (PKC) agonist phorbol 12, 13-dibutyrate (PDBu) elicited similar levels of contraction of DSM strips from normal and compensated bladders. However, PDBu-induced contraction decreased significantly in DSM strips from decompensated bladders. The expression and activity of PKC-alpha were also lowest in decompensated bladders. The PKC-specific inhibitor bisindolylmaleimide-1 (Bis) blocked PDBu-induced contraction and PKC activity in all three groups. Moreover, the phosphorylation of the phosphoprotein inhibitor CPI-17 (a 17-kDa PKC-potentiated inhibitory protein of protein phosphatase-1) was diminished in DSM from the decompensated bladder, which would result in less inhibitory potency of CPI-17 on myosin light chain phosphatase activity and contribute to less contractility. Immunostaining revealed the colocalization of PKC and phosphorylated CPI-17 in the DSM and confirmed the decreases of these signaling proteins in the decompensated bladder. Our results show a differential PKC-mediated DSM contraction with corresponding alterations of PKC expression, activity and the phosphorylation of CPI-17. Our finding suggests a significant correlation between bladder function and PKC pathway. An impaired PKC pathway appears to be correlated with severe bladder dysfunction observed in decompensated bladders.

Indexed as

AnimalsDisease Models, AnimalHumansHypertrophyIndolesIn Vitro TechniquesMaleMaleimidesMuscle ContractionMuscle ProteinsMuscle, SmoothPhosphoproteinsPhosphorylationPotassium ChlorideProtein Kinase CRabbitsbisindolylmaleimide ICPI-17 protein, Oryctolagus cuniculusIndolesMaleimidesMuscle ProteinsPhosphoproteinsPotassium ChlorideProtein Kinase CTetradecanoylphorbol Acetate

Identifiers

PMID19381130
PMCPMC2702459
OpenAlexW2110644698

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.